Refreshing results…
Targeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2
Download from doi.orgGenome-wide CRISPR screen reveals v-ATPase as a drug target to lower levels of ALS protein ataxin-2
Download from doi.orgTDP-43 represses cryptic exon inclusion in the FTD–ALS gene UNC13A
Download from www.nature.comNeurodegenerative disease: models, mechanisms, and a new hope
Download from doi.orgRegrowing axons with alternative splicing
Download from doi.orgCCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia
Download from www.nature.comMissing publications? Search for publications with a matching author name.